Anthony D'Adamio - 14 Mar 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Signature
/s/Anthony D'Adamio
Issuer symbol
BVS
Transactions as of
14 Mar 2022
Net transactions value
-$4,737
Form type
4
Filing time
16 Mar 2023, 21:21:20 UTC
Previous filing
15 Feb 2022
Next filing
05 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +8,887 +22% 49,019 14 Mar 2023 Direct F1
transaction BVS Class A Common Stock Sale $4,737 -3,409 -7% $1.39 45,610 15 Mar 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +35,545 $0.000000 35,545 14 Mar 2022 Class A Common Stock 35,545 Direct F1, F4
transaction BVS Restricted Stock Units Options Exercise $0 -8,887 -25% $0.000000 26,658 14 Mar 2023 Class A Common Stock 8,887 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 Reflects shares sold to cover taxes upon the vesting of the RSUs on March 14, 2023 pursuant to a standing 10b5-1 instruction.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.385 to $1.42, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The original grant of 35,545 RSUs vest in four approximately equal annual installments beginning on March 14, 2023.